Subject: | |
From: | |
Reply To: | |
Date: | Fri, 19 Oct 2001 07:16:32 EDT |
Content-Type: | text/plain |
Parts/Attachments: |
|
|
Someone pointed out that Cipro is:
> . It is classified as "usually
> > compatible with breastfeeding" in the newest AAP Policy Statement, "The
> > transfer of drugs and other chemicals into human milk"[Pediatrics 108:3,
> p
> > 799]. Thomas Hale places Cipro into lactation risk category L4, citing a
> > possible risk of serious joint and GI system side effects. Category L4
> > calls for a risk-benefit analysis before the decision is made to use the
> > drug in a breastfeeding mother. [Medications and Mothers' Milk, 2000
> > edition, pp 16, 147-8]
>
There was a notice on the news about Cipro causing arthroscopic problems in
dogs, but said it had never been demonstrated in humans, and that at the
doses babies receive, would not be a problem, My first and immediate
reaction to that was that the amount that babies would receive thru the
breastmilk would be even less of a problem than receiving it first hand.
Jan Barger, RN, MA, IBCLC -- Wheaton IL
Lactation Education Consultants
www.lactationeducationconsultants.com
***********************************************
The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(TM)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html
|
|
|